| Article
Last week, the US Department of Health and Human Services (HHS) announced the creation of a new task force to develop recommendations for acute and chronic pain management and to advance best practices for pain medication prescribing. Other government agencies involved in the initiative include the...
| Article
The 2016 CDC guidelines on opioid prescribing have been faulted in some quarters for a lack of scientific basis, and an article earlier this week discusses a recent study of the federal review process used in their development. Led by past PAINWeek faculty member Daniel Carr, MD, MA, professor of...
| Video
Concern over opioid abuse is amplifying interest in opioid induced hyperalgesia among governing bodies and payor organizations. Dr. Harden discusses the current state of the science surrounding OIH, including terminology, technology/methodology, and existing evidence. Additionally, he offers some...
| Video
In addition to other shortcomings, current prescribing guidelines are particularly ill-suited to the needs and challenges of patients already on opioid therapy. Drs. Heit and Gourlay discuss the roots of the problem and the role of primary care as talented amateurs in addiction medicine.
| Video
Public policy reaction to the opioid crisis has significant implications for practitioners and their patients with pain. Attorney Michael Barnes looks at the current federal and state-level regulatory picture, and at some benefits, drawbacks, and unintended consequences of regulatory response.
| Article
In a recent press release, the marketing research and strategic planning firm Pain Insights, Inc., announced the publication of a new study of patient views on the use of opioids, nonopioid analgesics, and nonpharmacologic therapies for the management of chronic pain. The study was undertaken to...
| Article
A new consensus report released last week by a panel of the National Academies of Sciences, Engineering, and Medicine urges a broad-based rethinking of our approach to chronic pain management, which would require changes in outlook and behavior from all stakeholders, including clinicians, patients...
| Article
The Federation of State Medical Boards (FSMB) recently released an updated version of its guidelines for prescribers in the use of opioid therapy for chronic pain. The revised document draws on recent advisories from the CDC and the FDA, and is intended to reflect the most current science for...
| Video
At PAINWeek 2016, a panel of medical, legal, and pharmacy specialists convened to offer their views on the recently introduced prescribing guidelines for chronic pain from the CDC. In this segment, Dr. Ziegler and Dr. Fudin summarize some of the concerns voiced over the guideline development process...
| Article
The use of interventional procedures is probably going to increase due to the CDC guidelines, because they are emphasizing non-opioid, and non-pharmacological therapies. So this is an important area for primary care doctors to understand, specifically if we look at patients with low back pain, one...